WCNA-0130,[1,1′-Biphenyl]-2-nitrile,4′-[(1,7′-dimethyl-2′-propyl[2,5′-bi-1H- benzimidazol]-1′-yl)methyl]-,Telmisartan
[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(1- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl]- CAS WCNA-0132
WCNA-0132,[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(1- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl]-,Telmisartan
2,5′-Bi-1H-benzimidazole, 3′-(( 2′-carboxybiphenyl-4-yl)methyl)-3′-((2′-carboxybiphenyl-4-yl) methyl)-1,7′-dimethyl-2′-propyl- CAS WCNA-0134
WCNA-0134,2,5′-Bi-1H-benzimidazole, 3′-(( 2′-carboxybiphenyl-4-yl)methyl)-3′-((2′-carboxybiphenyl-4-yl) methyl)-1,7′-dimethyl-2′-propyl-,Telmisartan
2,5′-Bi-1H-benzimidazole, 2′- (1-chloropropyl)-1,7′-dimethyl- CAS WCNA-0126
WCNA-0126,2,5′-Bi-1H-benzimidazole, 2′- (1-chloropropyl)-1,7′-dimethyl-,Telmisartan
[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,7′-dimethyl-2′- propyl[2,5′-bi-1H-benzimidazol]-3′-yl)methyl]-, methyl ester CAS WCNA-0128
WCNA-0128,[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,7′-dimethyl-2′- propyl[2,5′-bi-1H-benzimidazol]-3′-yl)methyl]-, methyl ester,Telmisartan
1H-Imidazo[4,5-c]quinoline, 4-chloro-1-(2-methylpropyl)-,5-oxide CAS WCNA-0113
WCNA-0113,1H-Imidazo[4,5-c]quinoline, 4-chloro-1-(2-methylpropyl)-,5-oxide,Imiquimod
[1,1′-Biphenyl]-2-carboxylic acid, 2′-[(1,4′-dimethyl-2′- propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]- CAS WCNA-0129
WCNA-0129,[1,1′-Biphenyl]-2-carboxylic acid, 2′-[(1,4′-dimethyl-2′- propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-,Telmisartan
Cyclopropaneacetic acid, 1-[[[1 -[3-[2-(7-chloro-2-quinolinyl) ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, ¦Á-hydroxy-, (R)- CAS WCNA-0114
WCNA-0114,Cyclopropaneacetic acid, 1-[[[1 -[3-[2-(7-chloro-2-quinolinyl) ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, ¦Á-hydroxy-, (R)-,Montelukast
Narlaprevir impurities CAS WCNA-0115
WCNA-0115,Narlaprevir impurities,Narlaprevir
[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(3- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl] CAS WCNA-0131
WCNA-0131,[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(3- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl],Telmisartan